STAT December 22, 2025
Atlas Venture’s Bruce Booth believes more drugmakers are ready to access public markets
One of the biotech industry’s most esteemed venture capitalists anticipates that, after two years of drought, a wave of drug companies will go public on the stock market.
“It will definitely change in 2026. We will see a lot more IPOs, is my prediction, than we’ve seen here this year and last year — two very barren years for IPOs,” Bruce Booth, a partner at Atlas Venture, who has been investing...
Today's Sponsors
Today's Sponsor